Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study.

Autor: Ferreira M; Department of Pneumology and Respiratory Functional Exploration, University Hospital of Tours, Tours, France., Swalduz A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Greillier L; Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France., du Rusquec P; Thorax Institute Curie Montsouris, Institut Curie, Paris, France., Curcio H; Centre François Baclesse, Caen, France., Raimbourg J; Department of Medical Oncology, ICO-Centre René Gauducheau, St Herblain, France., Toffart AC; Pulmonology Unit, Grenoble University Hospital, Grenoble, France., Gounant V; Service d'Oncologie Thoracique Hôpital Bichat, AP-HP, Paris, France., Couraud S; Acute Respiratory Medicine and Thoracic Oncology Department, Cancer Institute of Hospices Civils de Lyon, Lyon Sud Hospital, Pierre Bénite, France., De Chabot G; Centre Hospitalier Bretagne Atlantique, Vannes, France., Friard S; Hôpital Foch, Suresnes, France., Hureaux J; CHU Angers, Angers, France., Jeannin G; CHU Clermont-Ferrand, Clermont-Ferrand, France., Odier L; Hopital Nord-Ouest de Villefranche-sur-Saône, Gleize, France., Ricordel C; CHU Rennes, Rennes, France., Wislez M; Service de Pneumologie, Unité d'Oncologie Thoracique hôpital Cochin, AP-HP, Paris, France; Equipe 'Cancer, Immune Control and Escape' Inserm U1138 Centre de Recherches des Cordeliers Université de Paris Cité., Descarpentries C; Department of Biochemistry and Molecular Biology «Hormonology Metabolism Nutrition Oncology», CHU Lille, F-59000 Lille, France., Herbreteau G; Hôtel-Dieu, Laboratoire de biochimie, Plateforme de génétique des cancers, CHU Nantes, Nantes, France., Missy P; Intergroupe Francophone de Cancérologie Thoracique, Paris, France., Morin F; Intergroupe Francophone de Cancérologie Thoracique, Paris, France., Westeel V; Service de Pneumologie, Hôpital Jean Minjoz, Besançon, France., Cortot AB; Department of Thoracic Oncology, CHU de Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-U1277-CANTHER, Lille, France. Electronic address: alexis.cortot@chru-lille.fr.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Oct; Vol. 196, pp. 107934. Date of Electronic Publication: 2024 Aug 24.

A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study).

Autor: Jacob M; Department of Pneumonology and Thoracic Oncology, CHU, Saint-Etienne, France., Fournel P; Department of Pneumonology and Thoracic Oncology, CHU, Saint-Etienne, France., Tissot C; Oncology Department, Loire Private Hospital (HPL), Saint-Etienne, France., Cadranel J; Pneumology Department, Hôpital Tenon, APHP, France., Bylicki O; Pneumology Department, HIA Saint Anne, Toulon, France., Monnet I; Pneumology Department, CHICréteil, Créteil, France., Justeau G; Pneumology Department, CHU d'Angers, Angers, France., Ricordel C; Pneumology Department, CHU de Rennes, Rennes, France., Thomas P; Pneumology Department, CH Bastia, Bastia, France., Falchero L; Pneumology Department, CH Villefranche sur Soane,Villefranche sur Soane, France., Locher C; Pneumology Department, CH Meaux, Meaux, France., Wislez M; Pneumology Department, Hôpital Cochin, APHP, France., Vergnenegre A; Pneumology Department, CHU de limoges, Limoges France., Abdiche S; Pneumology Department, CH Libourne, Libourne, France., Guisier F; Pneumology Department, CHU de Rouen, Rouen, France., Bizieux A; Pneumology Department, CH, La Roche sur Yon, France., Lamy R; Pneumology Department, CH Lorient, Lorient, France., François G; Pneumology Department, CHU d'Amiens, Amiens, France., De Chabot G; Pneumology Department, CH Vannes,Vannes, France., Pierret T; Pneumology Department, Hospices civiles de Lyon, Lyon France., Sabatini M; Pneumology Department, CH Bayonne, Bayonne, France., Abeillera M; Pneumology Department, CH d'Annecy, Annecy, France., Vieillot S; Service d'Oncologie, Centre Catalan oncologie Perpignan, Perpignan, France., Martinez S; Pneumology Department, CH d'Aix en Provence, Aix en Provence France., Morel H; Pneumology Department, CH d'Orleans, Orleans, France., Doubre H; Pneumology Department, CH de Foch, Surenes, France., Madroszyk A; Service d'Oncologie, Institut paolo Calmette, Marseille, France., Geier M; Pneumology Department, CHU de Brest, Brest, France., LucLabourey J; Pneumology Department, CH de Carcassone, Carcassone France., Chouaïd C; Pneumology Department, CHICréteil, Créteil, France. Electronic address: Christos.chouaid@chicreteil.fr., Greillier L; Aix-Marseille University, APHM, INSERM, CNRS, CRCM, Hospital Nord, MultidisciplinaryOncology and Therapeutic Innovations Department, Marseille, France.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Aug; Vol. 194, pp. 107868. Date of Electronic Publication: 2024 Jul 11.

Resected EGFR -mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study).

Autor: Auliac JB; Service de Pneumologie, Pneumology Department, CHI Créteil, 40 Avenue de Verdun, Creteil 94010, France., Thomas PA; Thoracic Surgery Department, Assistance Publique Hopitaux de Marseille, Marseille, France., Bylicki O; Pneumology Department, Hôpital d'instruction des Armées Sainte-Anne, Toulon, France., Guisier F; Service de Pneumologie, Oncologie Thoracique et Soins Intensifs Respiratoires, CHU Rouen, Rouen, France., Curcio H; Oncology Department, Centre Francois Baclesse, Caen, France., AlainVegnenègre; Pneumology Department, CHU Limoges - Hopital Dupuytren, Limoges, France., Swalduz A; Department of Pneumology, Comprehensive Cancer Centre Léon Bérard, Lyon, France., Wislez M; Pneumology Department, Hôpital Cochin, AP-HP, Paris, France., Le Treut J; Pneumology Department, Hôpital Européen Marseille, Marseille, France., Decroisette C; Pneumology Department, Le Centre Hospitalier Annecy Genevois, Metz-Tessy, France., Basse V; Oncology Department, Clinique Saint-Yves, Vannes, France., Falchero L; Pneumology Department, Hospital Center De Villefranche-Sur-Saône, Gleizé, France., De Chabot G; Oncology Department, Centre Hospitalier Bretagne Atlantique, Vannes, France., Moreau D; Pneumology Department, Centre Hospitalier Universitaire de Saint Pierre de la Réunion, Saint-Pierre, Reunion Islands., Huchot E; Pneumology Department, Centre Hospitalier Universitaire Felix-Guyon, Saint Denis, France., Lupo Mansuet A; Service d'Anatomie-Pathologique, Hôpital Cochin, Université de Paris, AP-HP, Paris, France., Blons H; HEGP Biochimie, UF de Pharmacogénétique et Oncologie Moléculaire, Paris, France., Chouaïd C; Pneumology Department, CHI Créteil, Créteil, France., Greillier L; Multidisciplinary Oncology and Therapeutic Innovations, Hopital St. Marguerite Assistance Publique Hopitaux de Marseille, Marseille, France.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Mar 06; Vol. 16, pp. 17588359241236451. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).

Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

Autor: Ricordel, C, Anota, A., Bernardi, M., Falchero, L, Auliac, J. B., Greillier, L, Bylicki, O., de Chabot, G., Demaegdt, A., Vergnenegre, A, Decroisette, C, Martel-Lafay, I., Chouaid, C, Guisier, F.

Publikováno v: Annals of Oncology
Annals of Oncology, 2022, 33 (7), pp.S987-S987. ⟨10.1016/j.annonc.2022.07.1088⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2755::1de52f49045fba7ee8f48bc3154cafb6
https://hal.science/hal-03924724

1249P Health-related quality of life (HRQoL) at diagnosis for unresectable stage III NSCLC: Results from the French nationwide prospective study OBSTINATE (GFPC 06-2019)

Autor: Ricordel, C., Anota, A., Monnet, I., Martinez, S., Simmoneau, Y., Falchero, L., Guisier, F., De Chabot, G., Abdiche, S., Quere, G., Hominal, S., Demaegdt, A., Le Treut, J., Bayle, S., Pinsolle, J., Chatellier, T., Kaluzinski, L., Vieillot, S., Chouaid, C., Greillier, L.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S799-S800